Company news

Nyxoah SA news in 2026

Nyxoah SA's news releases, calls and decks from 2026, newest first.

View company

Nyxoah Appoints Liam Kelly as Chief Executive Officer

September 28, 2026

Nyxoah Announces Chief Financial Officer Transition

September 21, 2026

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

September 7, 2026

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients

September 2, 2026

Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results

August 5, 2026

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026

July 27, 2026

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

July 7, 2026

Nyxoah to Host Investor Day in New York on July 8, 2026

June 23, 2026

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026

June 19, 2026

Nyxoah Receives $15 Million from the European Investment Bank

June 17, 2026

Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology

June 15, 2026

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

June 10, 2026

Nyxoah Announces Closing of Underwritten Public Offering

June 10, 2026

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

June 5, 2026

Nyxoah Announces Proposed Offering of Ordinary Shares

June 4, 2026

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

May 20, 2026

Nyxoah Reports First Quarter 2026 Financial and Operating Results

May 12, 2026

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026

May 8, 2026

Nyxoah to Participate in the Bank of America 2026 Healthcare Conference

April 30, 2026

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

April 28, 2026

Publication relating to transparency notifications

March 20, 2026

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

March 19, 2026

Publication relating to transparency notification

March 13, 2026

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

March 11, 2026

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

March 5, 2026

Information on the total number of voting rights and shares

February 25, 2026

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

February 18, 2026

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

January 21, 2026

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026

January 12, 2026

Calls in 2026

Decks in 2026